Lion's Mane Mushroom: NGF Stimulation, Cognitive Benefits, and What the Human Trials Show
Updated: June 2026lion's mane mushroom · lion's mane supplement · lion's mane cognitive · hericium erinaceus · NGF lion's mane · lion's mane brain · lion's mane nootropic · lion's mane dosage · lion's mane benefits · lion's mane vs mycelium fruiting body · lion's mane anxiety · lion's mane dementia · lion's mane memory · lion's mane extract · functional mushrooms cognitive · lion's mane human studies
Lion's mane (Hericium erinaceus) occupies a unique position in the supplement landscape: it is one of the very few herbal/fungal supplements with a plausible, well-characterized mechanism for cognitive benefits (NGF stimulation), supported by multiple human RCTs showing measurable cognitive effects in older adults. This distinguishes it from the vast majority of nootropic supplements that rely primarily on in vitro data, animal studies, or single small trials.
Want the full evidence writeup?
The Stack Protocol builds four complete goal stacks — Energy, Focus, Sleep, Longevity — with exact doses, timing, budget tiers, and a 30-day rollout plan, graded with the same evidence framework behind this page.
Get the Stack Protocol → $19
The active compounds are hericenones (found primarily in the mushroom's fruiting body) and erinacines (found primarily in the mycelium — the root-like underground network). Both compound classes cross the blood-brain barrier as small molecules and upregulate endogenous NGF (Nerve Growth Factor) synthesis in the brain. NGF itself — a protein too large (26kDa in homodimer form) to cross the blood-brain barrier when administered directly — is a critical neurotrophic factor that promotes the survival, growth, and maintenance of neurons, particularly cholinergic neurons in the basal forebrain (which are among the first to degenerate in Alzheimer's disease). This NGF pathway gives lion's mane a mechanistic rationale that most nootropics lack.
16 wk
to cognitive effect — Mori 2009 (Phytother Res, N=30, RCT): the landmark lion's mane human trial; 30 adults 50–80 years old with mild cognitive impairment (MCI); treatment: 250mg dried Hericium erinaceus powder 3×/day (750mg/day total) for 16 weeks; outcome: MMSE (Mini-Mental State Examination) scores significantly higher in treatment group (23.4) vs placebo (21.4) at weeks 8, 12, and 16; important: cognitive improvements were reversed within 4 weeks of discontinuing supplementation — suggesting the effect requires ongoing supplementation to maintain; this reversal is actually evidence of a real pharmacological effect, not placebo
500–
1000mg
fruiting body equivalent daily dose — current dosing consensus based on available human trials and mechanistic studies; Mori 2009 used 750mg/day of dried powder (low potency); most modern extracts are standardized to higher hericenone/erinacine content, meaning 500–1000mg of a standardized extract delivers more active compound than the Mori trial dose; 8:1 or 10:1 extracts are common (10g mushroom → 1g extract); look for products listing beta-glucan content and hericenone/erinacine content on the label; minimum effective trial duration: 8 weeks (effects begin emerging); 12–16 weeks for full effect assessment
NGF
+↑
nerve growth factor upregulation — the central mechanism; Kawagishi 1994: first isolation of hericenones from fruiting body; Kawagishi 1996: erinacines identified in mycelium; both stimulate NGF mRNA expression and NGF protein synthesis in astrocytes and neurons; Nagano 2010 (Biomed Res): 2g lion's mane in cookies daily for 4 weeks reduced depression and anxiety scores in menopausal women (N=30) — possibly through NGF's role in hippocampal neurogenesis; the mechanism predicts therapeutic potential in conditions of NGF insufficiency: Alzheimer's, peripheral neuropathy, depression; human evidence for neurological disease conditions remains preliminary
Fruiting
Body
vs mycelium — important product distinction; hericenones are concentrated in the fruiting body (the white, tooth-like mushroom); erinacines are concentrated in the mycelium; most commercial lion's mane products are mycelium grown on grain (oats, brown rice) substrate; the problem: mycelium products often contain significant amounts of the grain substrate (starch), diluting the active compounds; some products may be primarily grain starch with minimal active fungal compounds; fruiting body extracts avoid this contamination; look for: fruiting body extraction, β-glucan content listed (≥30% indicates quality), no grain substrate in product; Examine.com's testing found significant potency variation across lion's mane products.